Study Stopped
Very low recruitment success and all recruitment options were exhausted
Effective Conversion of Individuals at Risk
1 other identifier
interventional
77
1 country
1
Brief Summary
This study aims to guide participants in recognizing their OSA (obstructive sleep apnea) and AFib (atrial fibrillation) symptoms, realizing what medical conditions can cause these symptoms (if any) and inform the participants on their possible diagnosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2021
CompletedFirst Posted
Study publicly available on registry
November 9, 2021
CompletedStudy Start
First participant enrolled
February 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2022
CompletedDecember 12, 2022
December 1, 2022
10 months
October 19, 2021
December 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effective conversion
Number of patients that visited the Primary Care Physician
6 months after consent
Study Arms (1)
Intervention
EXPERIMENTALSmartphone app use
Interventions
Eligibility Criteria
You may qualify if:
- High risk of OSA and/or AFib, as defined by the risk algorithm developed by Sanford health
- years or older, with sufficient English language skills
- Owning a smartphone with a relatively new operating system (iOS v. 14 (Iphone 6S or higher) or an Android device v.11\<)
- Able to download and handle an app on a smartphone
- Willing and able to give informed consent
You may not qualify if:
- Diagnosed with OSA and/or AFib
- Diagnosed health issues that are potentially life threatening or causing mental issues (stroke, Alzheimer's Disease, depression, etc.)
- Pregnancy/breast feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sandford Health
Sioux Falls, South Dakota, 57105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tim Weysen, MSc
Philips Healthcare
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2021
First Posted
November 9, 2021
Study Start
February 24, 2022
Primary Completion
December 8, 2022
Study Completion
December 8, 2022
Last Updated
December 12, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share